Hubert Chen
Plus aucun poste en cours
Fortune : 65 010 $ au 31/03/2024
Profil
Hubert C.
Chen is a former Associate Director-Medical Sciences at Amgen, Inc. He also worked as a Senior Director-Clinical Research at Amylin Pharmaceuticals, Inc. and as a Vice President-Clinical Development at Aileron Therapeutics, Inc. Additionally, he served as an Assistant Clinical Professor at The University of California, San Francisco and as a Staff Research Investigator at The J.
David Gladstone Institutes.
He held the position of Vice President-Translational Medicine at Regulus Therapeutics, Inc. and Chief Medical & Scientific Officer at Pelican Inc. He later became the Chief Medical Officer at Metacrine, Inc. Currently, he is the President & Chief Scientific Officer at Forte Biosciences, Inc. Dr. Chen holds a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from Stanford University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
FORTE BIOSCIENCES INC.
0,26% | 01/01/2024 | 93 405 ( 0,26% ) | 65 010 $ | 31/03/2024 |
Anciens postes connus de Hubert Chen
Sociétés | Poste | Fin |
---|---|---|
FORTE BIOSCIENCES, INC. | President | 15/03/2024 |
METACRINE, INC. | Chief Tech/Sci/R&D Officer | 31/12/2021 |
PFENEX INC. | Chief Tech/Sci/R&D Officer | 02/09/2018 |
AILERON THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2014 |
REGULUS THERAPEUTICS INC. | Corporate Officer/Principal | 01/01/2012 |
Formation de Hubert Chen
The Trustees of Columbia University in The City of New York | Doctorate Degree |
Stanford University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 5 |
---|---|
AMGEN INC. | Health Technology |
AILERON THERAPEUTICS, INC. | Health Technology |
REGULUS THERAPEUTICS INC. | Health Technology |
FORTE BIOSCIENCES, INC. | Health Technology |
METACRINE, INC. | Health Technology |
Entreprise privées | 3 |
---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
The J. David Gladstone Institutes
The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services The J. David Gladstone Institutes operates as an independent state-of-the-art biomedical research institution. The company was founded in 1979 and is headquartered in San Francisco, CA. | Commercial Services |
Pelican Inc
Pelican Inc BiotechnologyHealth Technology Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. Its products include PF708, PF743, PF745, CRM197, PF810, PF753 and PFXX. The company was founded on November 19, 2009 and is headquartered in San Diego, CA. | Health Technology |